An adoptee on why she won’t use 23andMe
The DNA Dilemma: Navigating the Future of Genetic Testing and Privacy The acquisition of 23andMe by Regeneron Pharmaceuticals has ignited a firestorm of debate, raising crucial questions about the future of genetic data. As a journalist who has spent years covering the intersection of technology, health, and privacy, I’ve seen firsthand the transformative potential of … Read more